Meitav Investment House’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $400K | Sell |
22,223
-13,294
| -37% | -$267K | ﹤0.01% | 205 |
|
|
2025
Q4 | $832K | Buy |
35,517
+4,004
| +13% | +$86.9K | 0.01% | 185 |
|
|
2025
Q3 | $629K | Sell |
31,513
-4,625
| -13% | -$83.1K | 0.01% | 186 |
|
|
2025
Q2 | $495K | Hold |
36,138
| – | – | 0.01% | 175 |
|
|
2025
Q1 | $400K | Hold |
36,138
| – | – | 0.01% | 183 |
|
|
2024
Q4 | $385K | Hold |
36,138
| – | – | 0.01% | 182 |
|
|
2024
Q3 | $459K | Sell |
36,138
-660
| -2% | -$9.8K | 0.01% | 175 |
|
|
2024
Q2 | $617K | Hold |
36,798
| – | – | 0.01% | 157 |
|
|
2024
Q1 | $552K | Sell |
36,798
-54,658
| -60% | -$893K | 0.01% | 168 |
|
|
2023
Q4 | $1.37M | Hold |
91,456
| – | – | 0.02% | 182 |
|
|
2023
Q3 | $1.29M | Sell |
91,456
-14,056
| -13% | -$226K | 0.02% | 187 |
|
|
2023
Q2 | $1.11M | Sell |
105,512
-1,700
| -2% | -$18.8K | 0.02% | 214 |
|
|
2023
Q1 | $1.25M | Sell |
107,212
-29,623
| -22% | -$273K | 0.02% | 207 |
|
|
2022
Q4 | $1.18M | Hold |
136,835
| – | – | 0.02% | 223 |
|
|
2022
Q3 | $1.13M | Hold |
136,835
| – | – | 0.02% | 227 |
|
|
2022
Q2 | $1.12M | Hold |
136,835
| – | – | 0.02% | 227 |
|
|
2022
Q1 | $1.19M | Sell |
136,835
-19,351
| -12% | -$151K | 0.02% | 250 |
|
|
2021
Q4 | $1.5M | Buy |
156,186
+29,596
| +23% | +$417K | 0.02% | 221 |
|
|
2021
Q3 | $2.13M | Buy |
126,590
+26,071
| +26% | +$413K | 0.03% | 199 |
|
|
2021
Q2 | $1.53M | Buy |
100,519
+37,239
| +59% | +$673K | 0.04% | 197 |
|
|
2021
Q1 | $1.23K | Buy |
+63,280
| New | +$1.34M | 0.03% | 195 |
|
|
2020
Q4 | – | Sell |
-48,407
| Closed | -$934K | – | 466 |
|
|
2020
Q3 | $934K | Buy |
48,407
+5,152
| +12% | +$117K | 0.05% | 164 |
|
|
2020
Q2 | $1.13M | Buy |
43,255
+12,849
| +42% | +$314K | 0.07% | 151 |
|
|
2020
Q1 | $544K | Sell |
30,406
-241,657
| -89% | -$6.53M | 0.04% | 217 |
|
|
2019
Q4 | $9.08M | Buy |
272,063
+23,470
| +9% | +$641K | 0.66% | 35 |
|
|
2019
Q3 | $6.31M | Sell |
248,593
-316,955
| -56% | -$10.4M | 0.45% | 37 |
|
|
2019
Q2 | $20.3M | Sell |
565,548
-300
| -0.1% | -$11.1K | 1.35% | 20 |
|
|
2019
Q1 | $20.9M | Buy |
565,848
+147,358
| +35% | +$6.18M | 1.17% | 23 |
|
|
2018
Q4 | $18M | Sell |
418,490
-165,614
| -28% | -$7.45M | 1.12% | 29 |
|
|
2018
Q3 | $27.8M | Buy |
584,104
+74,749
| +15% | +$3.47M | 1.36% | 22 |
|
|
2018
Q2 | $30M | Buy |
509,355
+62,003
| +14% | +$3.61M | 1.34% | 22 |
|
|
2018
Q1 | $22.2M | Buy |
447,352
+34,470
| +8% | +$1.73M | 1.13% | 31 |
|
|
2017
Q4 | $15.4M | Buy |
+412,882
| New | +$14.7M | 0.9% | 41 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
